These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
179 related articles for article (PubMed ID: 11412682)
1. [Statins: an intriguing nexus between osteoporosis and atherothrombosis]. Pérez Jiménez F; Quesada Gómez JM Med Clin (Barc); 2001 May; 116(18):696-7. PubMed ID: 11412682 [No Abstract] [Full Text] [Related]
2. Lack of negative interaction between use of β-blockers and statins on cardiovascular outcomes among patients with or at risk for atherothrombosis. Abtan J; Elbez Y; Bhatt DL; Steg PG J Am Coll Cardiol; 2014 Aug; 64(8):845-7. PubMed ID: 25145532 [No Abstract] [Full Text] [Related]
4. Inflammation, oxidative stress, and atherosclerosis. Le NA Curr Opin Lipidol; 2004 Apr; 15(2):227-9. PubMed ID: 15017368 [No Abstract] [Full Text] [Related]
5. Statins and stroke: evidence for cholesterol-independent effects. Di Napoli P; Taccardi AA; Oliver M; De Caterina R Eur Heart J; 2002 Dec; 23(24):1908-21. PubMed ID: 12473253 [No Abstract] [Full Text] [Related]
6. Statins and plaque stability. Gomberg-Maitland M; Fuster V; Fayad ZA; Badimon JJ; Corti R J Cardiovasc Risk; 2003 Jun; 10(3):161-7. PubMed ID: 12775948 [TBL] [Abstract][Full Text] [Related]
7. Statins and osteoporosis: can these lipid-lowering drugs also bolster bones? Cruz AC; Gruber BL Cleve Clin J Med; 2002 Apr; 69(4):277-8, 280-2, 287-8. PubMed ID: 11996199 [TBL] [Abstract][Full Text] [Related]
8. [Antilipemic agents and atherothrombosis. Effects of antilipemic agents on blood platelet function, coagulation and fibrinolysis]. Sinzinger H Dtsch Med Wochenschr; 1998 Sep; 123(38):1116-22. PubMed ID: 9787294 [No Abstract] [Full Text] [Related]
9. 3-Hydroxy-3-methylglutaryl coenzyme a (HMG-CoA) reductase inhibitors (statins), atherosclerosis and coronary syndromes. Blum A; Simsolo C; Hasin Y Atherosclerosis; 2004 Jul; 175(1):1-5. PubMed ID: 15186940 [No Abstract] [Full Text] [Related]
10. [Pleiotrophic effect of statins (3-hydroxy-3-methylglutaryl-coenzyme a reductase inhibitors)]. Igel M; Sudhop T; von Bergmann K Arzneimittelforschung; 2003; 53(8):545-53. PubMed ID: 13677244 [TBL] [Abstract][Full Text] [Related]
12. Essential fatty acids as possible mediators of the actions of statins. Das UN Prostaglandins Leukot Essent Fatty Acids; 2001 Jul; 65(1):37-40. PubMed ID: 11487306 [TBL] [Abstract][Full Text] [Related]
13. [Non-lipid effects of statins in atherosclerosis]. Lévesque H Rev Med Interne; 2004 Nov; 25(11):783-5. PubMed ID: 15501346 [No Abstract] [Full Text] [Related]
14. [What other effects do statins have except their effect on lipids?]. Tikkanen MJ Duodecim; 1998; 114(13):1299-301. PubMed ID: 11552256 [No Abstract] [Full Text] [Related]
15. [Statins and osteoporosis]. Astesana P; Gobbi CA; Alba P; Yorio MA Rev Fac Cien Med Univ Nac Cordoba; 2015; 72(1):39-43. PubMed ID: 26273947 [No Abstract] [Full Text] [Related]
16. Hydroxymethylglutaryl-coenzyme A reductase inhibitors in osteoporosis management. Coons JC Ann Pharmacother; 2002 Feb; 36(2):326-30. PubMed ID: 11847956 [TBL] [Abstract][Full Text] [Related]
17. [Statins and osteoporosis]. Svejda P Vnitr Lek; 2006 Dec; 52(12):1190-3. PubMed ID: 17299913 [TBL] [Abstract][Full Text] [Related]
18. Bisphosphonates, statins, osteoporosis, and atherosclerosis. Watts N South Med J; 2002 Jun; 95(6):578-82. PubMed ID: 12081213 [No Abstract] [Full Text] [Related]
19. [Inhibitors of HMG-CoA reductase in prevention of osteoporosis and bone fractures. Similar mechanism of action of statins and bisphosphonates]. Stajszczyk M; Mykała-Cieśla J Pol Arch Med Wewn; 2002 Jan; 107(1):85-91. PubMed ID: 12046350 [No Abstract] [Full Text] [Related]
20. [Statins--new mechanisms of action and new indications]. Savolainen M Duodecim; 2000; 116(24):2833-8. PubMed ID: 12077889 [No Abstract] [Full Text] [Related] [Next] [New Search]